Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT.

Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT.

Item
http://www.wikidata.org/entity/Q37315405
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyTreosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.Busulfan in hematopoietic stem cell transplant setting.High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation.Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan.Conditioning regimens in allo-SCT for thalassemia major.Optimizing drug therapy in pediatric SCT: focus on pharmacokinetics.Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Nonmyeloablative conditioning generates autoantigen-encoding bone marrow that prevents and cures an experimental autoimmune disease.High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study.Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation.Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia.European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies.Treosulfan Pharmacokinetics and its Variability in Pediatric and Adult Patients Undergoing Conditioning Prior to Hematopoietic Stem Cell Transplantation: Current State of the Art, In-Depth Analysis, and Perspectives.Development and Validation of a High Pressure Liquid Chromatography-UV Method for the Determination of Treosulfan and Its Epoxy Metabolites in Human Plasma and Its Application in Pharmacokinetic Studies.
P2860

Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT.

Item
http://www.wikidata.org/entity/Q37315405
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics of high-dose ...... allogeneic haematopoietic SCT.
@en
Pharmacokinetics of high-dose ...... allogeneic haematopoietic SCT.
@nl
type
label
Pharmacokinetics of high-dose ...... allogeneic haematopoietic SCT.
@en
Pharmacokinetics of high-dose ...... allogeneic haematopoietic SCT.
@nl
prefLabel
Pharmacokinetics of high-dose ...... allogeneic haematopoietic SCT.
@en
Pharmacokinetics of high-dose ...... allogeneic haematopoietic SCT.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P407
P478
P50
P577
P698
P356
P1433
P1476
Pharmacokinetics of high-dose ...... allogeneic haematopoietic SCT.
@en
P2093
P2888
P304
P31
P356
P407
P478
P50
P577
P698